Companies / Consumer Staples
KO
Coca-Cola Company (The)
Soft Drinks & Non-alcoholic Beverages
Soft Drinks & Non-alcoholic BeveragesAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health55
Growth34
Profitability89
Cash generation37
Balance sheet37
Dilution control79
Key ratios and five-year financials
Latest quarter revenue YoY (2026-10-02)7.4%Revenue growth (FY)1.9%Revenue CAGR (3y)3.7%Gross margin61.6%Operating margin28.7%Net margin27.3%Free cash flow margin11.0%R&D / revenue—Stock comp / revenue0.6%Net debt / operating cash flow4.50xCurrent ratio1.46Diluted share count change-0.2%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $38.7B | $43.0B | $45.8B | $47.1B | $47.9B |
| Gross profit | $23.3B | $25.0B | $27.2B | $28.7B | $29.5B |
| Operating income | $10.3B | $10.9B | $11.3B | $10.0B | $13.8B |
| Net income | $9.8B | $9.5B | $10.7B | $10.6B | $13.1B |
| Operating cash flow | $12.6B | $11.0B | $11.6B | $6.8B | $7.4B |
| Capital expenditure | $1.4B | $1.5B | $1.9B | $2.1B | $2.1B |
| Free cash flow | $11.3B | $9.5B | $9.7B | $4.7B | $5.3B |
| Stock-based comp | $337M | $356M | $254M | $286M | $279M |
| Buybacks | $111M | $1.4B | $2.3B | $1.8B | $746M |
| Dividends | $7.3B | $7.6B | $8.0B | $8.4B | $8.8B |
| Cash | $9.7B | $9.5B | $9.4B | $10.8B | $10.3B |
| Total debt | $44.1B | $39.5B | $43.7B | $43.5B | $43.6B |
| Equity | $23.0B | $24.1B | $25.9B | $24.9B | $32.2B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.